Monthly Archives: September 2011

Acute Coronary Syndromes, “Answers,” IV/IV

4. How reassuring is a recent (< 1 year) negative stress test in managing a patient with chest pain? How about a recent “normal” cath (i.e., < 30% blockage, no intervention)? In a word (or two): not very. The problem … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

Acute Coronary Syndromes, “Answers,” III/IV

3.  How do you risk stratify patients with chest pain?  Do you use any clinical decision rules? It’s a daily ED conundrum: how concerning is this patient’s chest pain? This most common, yet challenging, clinical quandary is not an insignificant one … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

Acute Coronary Syndromes, “Answers” II/IV

2.  How do you identify and manage patients with unstable angina? Patients with unstable angina (UA) are  on the same ACS spectrum as NSTEMIs and STEMIs.  Unstable angina is defined as either angina at rest, new onset (< 2 months) … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

Acute Coronary Syndromes, “Answers”

NB: For this topic, perhaps the most researched in all of modern medicine, we are going to break up the answers to avoid dyspepsia. Our apologies for the extra emails. 1.     What anti-coagulants and/or anti-platelet agents do you use in … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

RSI Episode 2: Induction, Questions

Coming soon: the finale to our August 2011 magnum opus on ACS! September 2011 1. What are the optimal characteristics for an induction agent for RSI? 2. What are the pros and cons for the following induction agents: etomidate, ketamine, … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment